Equities

Fonet Bilgi Teknolojileri AS

FONET.E:IST

Fonet Bilgi Teknolojileri AS

Actions
Health CareMedical Equipment and Services
  • Price (TRY)18.78
  • Today's Change-0.36 / -1.88%
  • Shares traded4.69m
  • 1 Year change+265.65%
  • Beta1.1455
Data delayed at least 15 minutes, as of Sep 20 2024 16:09 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in TRYIncome statement in TRYView more

Year on year Fonet Bilgi Teknolojileri AS grew revenues 5.36% from 237.11m to 249.81m while net income improved 520.64% from 23.96m to 148.71m.
Gross margin27.24%
Net profit margin48.10%
Operating margin20.71%
Return on assets28.55%
Return on equity33.55%
Return on investment32.44%
More ▼

Cash flow in TRYView more

In 2023, cash reserves at Fonet Bilgi Teknolojileri AS fell by 26.57m. However, the company earned 116.15m from its operations for a Cash Flow Margin of 46.50%. In addition the company generated 3.80m cash from financing while 146.53m was spent on investing.
Cash flow per share2.68
Price/Cash flow per share8.69
Book value per share6.32
Tangible book value per share0.9364
More ▼

Balance sheet in TRYView more

Fonet Bilgi Teknolojileri AS uses little debt in its capital structure as supported by a debt to capital ratio of 0.62%.
Current ratio1.72
Quick ratio1.72
Total debt/total equity0.0063
Total debt/total capital0.0062
More ▼

Growth rates in TRY

Year on year, growth in earnings per share excluding extraordinary items increased 2,057.28%. Additionally, five year annualized earnings per share growth ranks highest in its industry.
EPS growth(5 years)111.42
EPS (TTM) vs
TTM 1 year ago
1,057.09
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.